Paper Details

  1. Home
  2. Paper Details

Selective Serotonin Reuptake Inhibitors.

Author: LochmannDee, RichardsonTara

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

SSRIs, rationally designed to be safer than previous antidepressants, are a class of psychotropic medications with varying pharmacokinetic profiles and effects on CYP450 enzymes.
Paper Details　
Original Abstract of the Article :
The first antidepressants were created by chance but brought the idea that central serotonin agonism produced an antidepressant effect. SSRIs were the first class of psychotropic medications to be rationally designed, meaning that researchers intended to utilize a specific mechanism of action while ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1007/164_2018_172

データ提供：米国国立医学図書館（NLM）

SSRI: A Look Back at the Evolution of Antidepressant Therapy

The [psychiatric field] has seen significant advances in the treatment of [depression], with the development of [selective serotonin reuptake inhibitors (SSRIs)]. This study examines the history and evolution of [SSRIs], highlighting their [rationale design] and [mechanisms of action]. The authors provide a comprehensive overview of [SSRI] characteristics, including [pharmacokinetics], [effects on CYP450 enzymes], [safety], [clinical indications], and [dosing recommendations]. This review serves as a valuable resource for understanding the role of [SSRIs] in [depression treatment] and their significance in [mental health care].

A Step Towards Personalized Depression Treatment

This study emphasizes the importance of understanding the [pharmacokinetic] and [pharmacodynamic] properties of [SSRIs] for optimizing [depression treatment]. The information provided can help clinicians tailor [SSRI] selection and dosage to individual patient needs, promoting more effective and safer treatment. This research highlights the transition from a one-size-fits-all approach to a more personalized approach in [mental health care].

Navigating the Desert of Mental Health

This study offers a valuable perspective on the evolution of [antidepressant therapy]. It's a reminder that progress in [mental health care] is an ongoing journey, with new discoveries and advancements constantly shaping our understanding of [depression] and its treatment. This research is a stepping stone on our path towards a more comprehensive and effective approach to managing mental health challenges.

Dr.Camel's Conclusion

The development of [SSRIs] represents a significant milestone in the [psychiatric field]. It's like finding a well of hope in the vast desert of [depression], offering a lifeline to those struggling with this debilitating condition. This research serves as a reminder that our understanding of [mental health] is constantly evolving, and with continued research and innovation, we can continue to improve the lives of those affected by [depression].

Date :
  1. Date Completed 2019-07-22
  2. Date Revised 2022-12-07
Further Info :

Pubmed ID

30838457

DOI: Digital Object Identifier

10.1007/164_2018_172

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.